Seville, 14 February 2024
One year after the kickoff meeting, the 31st of January 2024 the study BIOSHIP-training closed up the recruitment phase after reaching more than 380 patients enrolled in 9 months.
The aim of this study is to evaluate the potential use of a rapid Point-of-Care device for the direct transfer of stroke patients with a large vessel occlusion (LVO) from the ambulance to the thrombectomy centers. When we talk of stroke, time is brain, as the damaged neuronal tissue may be irrecoverable if the treatment is performed too late. The possibility to identify the LVOs at a prehospital level and save time to decide the final therapeutic approach will benefit the recovery of the patients presenting this time-dependent condition.
Finally, the study counted on the collaboration of 16 hospitals and 34 ambulance teams from 6 Spanish autonomous regions: Andalucía, La Rioja, Castilla y León, Castilla la Mancha, Aragón and Comunidad Valenciana. Since the beginning of the study, more than 400 healthcare professionals from the emergency teams and hospitals have been trained for the use of this POC device.
Thanks to their huge effort and commitment to this project, it has been able to obtain valuable data that hopefully will open up the possibility to perform endovascular thrombectomy (EVT) sooner, thus allowing a better prognosis for the patients suffering from LVO stroke. Being able to launch this project has also led to invaluable feedback about the POC device and its use in an emergency situation, giving us key points to simplify and make it even easier to use in the future.
Currently, the follow-up period (3 months after the stroke episode) of the patients is ongoing and the final results are estimated to be reached by the end of April.
BIOSHIP-training has been supported by the Junta de Andalucía (PIP-0009-2021, a public-private partnership with ABCDx, and PIN-0139-2020) and the Ministerio de Ciencia eInnovación (TED2021-131742B-I00), coordinated from the Hospital Universitario Virgen Macarena (Sevilla) by the Dr. Ana Barragán and lead by the Dr. Joan Montaner.
For further information, please contact:
Rosa M. Delgado at Rosa.Delgado@abcdx.ch